Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in nonhuman primates, suggesting the approach may be used to treat B-cell diseases such as multiple sclerosis (MS) and some cancers. […]
The post CAR-M cell therapy shows promise in preclinical studies appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com